Board and Board Committee Changes

RNS Number : 5468F
Accrol Group Holdings PLC
29 October 2018
 

 

For immediate release on 29 October 2018

 

Accrol Group Holdings plc

("Accrol Group" or the "Company")

AIM: ACRL

 

Board and Board Committee Changes

 

Accrol Group, the UK's leading independent tissue converter, announces that Joanne Lake has given notice that she wishes to step down from the Board and leave the Company with effect from today to pursue other opportunities, alongside her existing portfolio of chairman and non-executive director responsibilities.

Simon Allport, who joined the Board on 10 October 2018, replaces Joanne as Chairman of the Audit Committee with immediate effect.

Following Joanne's departure, the Directors will continue discussions with other potential non-executive directors to further strengthen the Board in due course.

Dan Wright, Executive Chairman of Accrol Group, said: "I would like to thank Joanne for her contribution to the Board, particularly during the two fundraisings that were undertaken to secure the future of the business. On behalf of the Board, I wish her all the best for the future."

 

For further information, please contact:

 

 

 

Accrol Group Holdings plc

 

Dan Wright, Executive Chairman

Tel: +44 (0) 1254 278 844

Gareth Jenkins, Chief Executive Officer

 

Steve Townsley, Chief Financial Officer

 

 

 

Zeus Capital Limited (Nominated Adviser & Broker) 

 

Dan Bate / Andrew Jones            

Tel: +44 (0) 161 831 1512

Dominic King / John Goold

Tel: +44 (0) 203 829 5000

 

 

Belvedere Communications Limited

 

Cat Valentine (cvalentine@belvederepr.com)

Tel: +44 (0) 7715 769 078

Llew Angus (langus@belvederepr.com)

Tel: +44 (0) 7407 023 147

 

 

 

Notes to Editors

 

Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues, as well as other tissue products, to major discounters and grocery retailers throughout the UK. 

 

Accrol operates from three sites:

 

·      A manufacturing, storage and distribution facility in Blackburn;

·      A facial tissue plant, also in Blackburn; and

·      A manufacturing, storage and distribution facility in Leyland.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUKUARWOARUAA
UK 100